These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19564018)

  • 1. Risk stratification for therapeutic management and prognosis.
    Coelho-Filho OR; Nallamshetty L; Kwong RY
    Heart Fail Clin; 2009 Jul; 5(3):437-55, vii. PubMed ID: 19564018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance in the evaluation of hypertrophic and infiltrative cardiomyopathies.
    O'Hanlon R; Pennell DJ
    Heart Fail Clin; 2009 Jul; 5(3):369-87, vi. PubMed ID: 19564014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance assessment of ischemic and nonischemic cardiomyopathies.
    Raney AR; Bello D
    Heart Fail Clin; 2006 Apr; 2(2):145-61. PubMed ID: 17386886
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical applications of cardiac magnetic resonance imaging.
    Pilz G; Heer T; Harrer E; Ali E; Hoefling B
    Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of cardiac magnetic resonance imaging in cardiomyopathy.
    Steel KE; Kwong RY
    Curr Heart Fail Rep; 2008 Sep; 5(3):128-35. PubMed ID: 18752762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of cardiac CMR.
    Al-Mallah M; Kwong RY
    Rev Cardiovasc Med; 2009; 10(3):134-41. PubMed ID: 19898290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac magnetic resonance imaging derived quantification of myocardial ischemia and scar improves risk stratification and patient management in stable coronary artery disease.
    Buckert D; Cieslik M; Tibi R; Radermacher M; Rottbauer W; Bernhardt P
    Cardiol J; 2017; 24(3):293-304. PubMed ID: 28353309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MRI in cardiac sarcoidosis and amyloidosis].
    Bauner KU; Wintersperger B
    Radiologe; 2013 Jan; 53(1):54-60. PubMed ID: 23242036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease.
    Jerosch-Herold M; Kwong RY
    Curr Opin Cardiol; 2008 Nov; 23(6):599-606. PubMed ID: 18830076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance myocardial perfusion imaging at 3.0 Tesla for the identification of myocardial ischaemia: comparison with coronary catheter angiography and fractional flow reserve measurements.
    Ebersberger U; Makowski MR; Schoepf UJ; Platz U; Schmidtler F; Rose J; Kessel A; Roth P; Antoni D; Schnackenburg B; Helmberger T; Rieber J; Hoffmann E; Leber AW
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1174-80. PubMed ID: 23907345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular magnetic resonance imaging in ischemic heart disease.
    von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
    J Magn Reson Imaging; 2012 Jul; 36(1):20-38. PubMed ID: 22696124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].
    Stork A; Müllerleile K; Bansmann PM; Koops A; Meinertz T; Adam G; Lund GK
    Rofo; 2007 Jan; 179(1):21-30. PubMed ID: 17203440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac magnetic resonance imaging for myocarditis and nonischemic cardiomyopathies.
    Wassmuth R
    Minerva Cardioangiol; 2009 Aug; 57(4):511-20. PubMed ID: 19763072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress perfusion magnetic resonance imaging to detect coronary artery lesions in children.
    Vijarnsorn C; Noga M; Schantz D; Pepelassis D; Tham EB
    Int J Cardiovasc Imaging; 2017 May; 33(5):699-709. PubMed ID: 28000002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac magnetic resonance imaging for stage B heart failure.
    Partington SL; Cheng S; Lima JA
    Heart Fail Clin; 2012 Apr; 8(2):179-90. PubMed ID: 22405659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAD detection in patients with intermediate-high pre-test probability: low-dose CT delayed enhancement detects ischemic myocardial scar with moderate accuracy but does not improve performance of a stress-rest CT perfusion protocol.
    Bettencourt N; Ferreira ND; Leite D; Carvalho M; Ferreira WDS; Schuster A; Chiribiri A; Leite-Moreira A; Silva-Cardoso J; Nagel E; Gama V
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1062-1071. PubMed ID: 24011773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular magnetic resonance: applications and practical considerations for the general cardiologist.
    Arnold JR; McCann GP
    Heart; 2020 Feb; 106(3):174-181. PubMed ID: 31826937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving diagnostic and prognostic imaging of the various cardiomyopathies.
    Sanz J
    Ann N Y Acad Sci; 2012 Apr; 1254():123-130. PubMed ID: 22548578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value and prognostic implications of early cardiac magnetic resonance in survivors of out-of-hospital cardiac arrest.
    Zorzi A; Susana A; De Lazzari M; Migliore F; Vescovo G; Scarpa D; Baritussio A; Tarantini G; Cacciavillani L; Giorgi B; Basso C; Iliceto S; Bucciarelli Ducci C; Corrado D; Perazzolo Marra M
    Heart Rhythm; 2018 Jul; 15(7):1031-1041. PubMed ID: 29550522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prominent role of cardiac magnetic resonance imaging in coronary artery disease.
    Palios J; Karangelis D; Roubelakis A; Lerakis S
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):167-74. PubMed ID: 24417312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.